Compare CSBR & SAMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CSBR | SAMG |
|---|---|---|
| Founded | 1985 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 81.0M | 76.4M |
| IPO Year | 2015 | 2012 |
| Metric | CSBR | SAMG |
|---|---|---|
| Price | $5.07 | $10.18 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 8.7K | ★ 53.2K |
| Earning Date | 03-12-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 6.36% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.05 |
| Revenue | $2,900,000.00 | ★ $91,358,000.00 |
| Revenue This Year | $4.84 | $8.99 |
| Revenue Next Year | $11.51 | N/A |
| P/E Ratio | ★ N/A | $203.40 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.88 | $9.57 |
| 52 Week High | $8.74 | $16.88 |
| Indicator | CSBR | SAMG |
|---|---|---|
| Relative Strength Index (RSI) | 35.96 | 46.64 |
| Support Level | N/A | $9.64 |
| Resistance Level | $6.31 | $11.61 |
| Average True Range (ATR) | 0.34 | 0.39 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 7.50 | 36.71 |
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income, and cash, as well as non-traditional investment strategies including hedge funds, private equity funds, real estate, and commodities. The firm offers a full suite of complementary and customized family office services for families seeking comprehensive oversight of their financial affairs. The company derives revenues from Managed accounts, Silvercrest funds, Tax and family office services, and Fund administration. The firm generates the majority of its revenue from Managed Accounts.